December 8, 2016 – (LOS ANGELES / NEW YORK) – Be The Breakthrough™ Celebrates Progress Against Cancer and Calls on Everyone to Play a Role in Fight Against Disease
November 10, 2016 - Stand Up To Cancer (SU2C) is making $7.5 million in research grants available to early-career scientists who are pursuing innovative cancer research projects focusing on immuno-oncology, the American Association for Cancer Research (AACR) announced today.
November 3, 2016 - Stand Up To Cancer (SU2C) announced today an SU2C Catalyst™ collaboration with Genentech, a member of the Roche Group, that will help accelerate the development of new cancer treatments and combination therapies by giving awardees funding and access to a dozen of the company’s medicines.
October 24, 2016 - (Business Wire)--Bristol-Myers Squibb’s (NYSE:BMY) Coast 2 Coast 4 Cancer has raised more than $1,050,000 to support Stand Up To Cancer’s collaborative cancer research programs.
October 20, 2016 - Stand Up To Cancer (SU2C) announced today it will launch a new attack on colorectal cancer, committing up to $7 million (US) for a new Dream Team to find ways to improve treatment of the disease. The American Association for Cancer Research (AACR), SU2C’s scientific partner, issued a “Call for Ideas” to invite proposals from the scientific community to form a Dream Team.